CHEBI:15765Papers
Papers about CHEBI:15765
- papers
- 68
Newest first
51 to 68 of 68Every paper here, unless its row says otherwiseIndexed under CHEBI:15765 in PubMed's chemical list
Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease.
Clinical neuropharmacology2004PMID 15190235
Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
Renal failure2004PMID 15462107
Levodopa and the progression of Parkinson's disease.
The New England journal of medicine2004PMID 15590952Tests CHEBI:15765
Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.
Movement disorders2003PMID 12722164
Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
Movement disorders2003PMID 14534913Tests CHEBI:15765
Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
The Journal of clinical psychiatry2002PMID 12088163
The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
Movement disorders2002PMID 12210856
Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
Movement disorders1999PMID 10348474
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
Psychopharmacology1999PMID 10591873
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.
Neurology1996PMID 8649546
Screening test for growth hormone deficiency: usefulness of L-dopa-propranolol provocative test.
Journal of paediatrics and child health1994PMID 7946545Also indexed under CHEBI:15765 as a PubMed major topic
Progression after chronic manganese exposure.
Neurology1993PMID 8351000
Pharmacologic maintenance of abstinence in patients with alcoholism: no efficacy of 5-hydroxytryptophan or levodopa.
Clinical pharmacology and therapeutics1992PMID 1424429Also compares against CHEBI:15765
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
Journal of neural transmission1990PMID 1977409
Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
The Journal of clinical endocrinology and metabolism1990PMID 2318945
Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
Clinical endocrinology1988PMID 3145820
L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression.
Neuropsychobiology1988PMID 3265988
Reversal of ethanol intoxication in humans: an assessment of the efficacy of L-dopa, aminophylline, and ephedrine.
Psychopharmacology1977PMID 414280